Dr. Anthony E. Albregts, MD

Dr. Albregts practices at Mountain West Derm - Blackhart in Reno, Nevada.

Dr. Albregts' NPI, 1093718751, was assigned on May 24, 2005. Dr. Albregts graduated from Indiana University School Of Medicine in 1992. Dr. Albregts holds Nevada license 7811.

Dr. Albregts' primary practice is Mountain West Derm - Blackhart, at 5419 Reno Corporate Dr, Reno, NV 89511 in Washoe County. The practice phone is (775) 324-0699.

Dr. Albregts' primary practice is Mountain West Derm - Blackhart in Reno, Nevada. The medical group on file is Advanced Dermatology & Skin Surgery. Dmand AI also links Dr. Albregts to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Albregts practices. Vendor and product names are available with a free account.

Dermatology is Dr. Albregts' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Albregts is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Albregts' licenses on file in 4 states: Nevada, California, Texas and Washington.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and itchy rashes among the conditions Dr. Albregts treats.

CMS data shows 4,194 Medicare services from Dr. Albregts across 20 procedure codes in 2024, for 391 Medicare patients. Medicare paid $173,953 for them. Every service was in an office.

CMS counts 391 Medicare patients who saw Dr. Albregts in 2024. The largest group is 75 to 84, with 182 patients. 75% of them have high cholesterol, and 66% have high blood pressure. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Albregts' median patient age at 69, with 30% women.

In 2024, Dr. Albregts wrote 351 Medicare Part D claims for 188 patients. 99% of them were for generic drugs. CMS names the drug for 296 of them, across 9 drugs with 11 or more claims each, at $6,703 in total drug cost. In 2023, CMS named 294 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Albregts for performance year 2024, reported as part of a group. Dr. Albregts accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 711 procedures of skin biopsy by Dr. Albregts, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Albregts. The most frequent topics are Hemangioma. Dr. Albregts' most frequent co-authors are Adelaide A. Hebert, MD and Ronald P. Rapini, MD.

CMS Open Payments shows 59 general payments to Dr. Albregts from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $300.

Dr. Albregts graduated from Indiana University School Of Medicine in 1992.

Dr. Albregts is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.